The self/nonself issue a confrontation between proteomes

Self/Nonself - Immune Recognition and Signaling

Volumn 1, Issue 3, 2010, Pages 255-258

  Kanduc, Darja ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

Epitopic peptides; Immune recognition; Proteomic analysis; Self nonself

Indexed keywords

ADENOSINE A2A RECEPTOR; ADHESIN; ALLERGEN; AMINO ACID; ANTIBODY; AUTOANTIBODY; BINDING PROTEIN; BLOOD CLOTTING FACTOR 8; CHEMOKINE RECEPTOR CXCR1; CHEMOKINE RECEPTOR CXCR2; COLLAGEN TYPE 4; DNA; EPITOPE; GLYCOPROTEIN GP 41; MELANIN CONCENTRATING HORMONE RECEPTOR 1; NONSTRUCTURAL PROTEIN 1; OSTEOPONTIN; PROSTATE SPECIFIC ANTIGEN; PROTEOME; VIRUS GLYCOPROTEIN; VIRUS HEMAGGLUTININ;

ALLERGY; AMINO ACID SEQUENCE; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIGEN RECOGNITION; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; EPITOPE MAPPING; HUMAN; IMMUNOGENICITY; IMMUNOLOGICAL TOLERANCE; INFECTION; NEOPLASM; PROTEIN MOTIF; SEQUENCE HOMOLOGY;

EID: 78049304049     PISSN: 19382030     EISSN: 19382049     Source Type: Journal    
DOI: 10.4161/self.1.3.11897     Document Type: Article

References (53)

1. Van Regenmortel MH. What is a B-cell epitope? Methods Mol Biol 2009; 524:3-20.
2. Kanduc D. Peptimmunology: immunogenic peptides and sequence redundancy. Curr Drug Discov Technol 2005; 2:239-44.
3. Lim PL, Zouali M. Pathogenic autoantibodies: emerging insights into tissue injury. Immunol Lett 2006; 103:17-26.
4. Tauber AI. The elusive immune self: a case of category errors. Perspect Biol Med 1999; 42:459-74.
5. Cohn M. On the opposing views of the self-nonself discrimination by the immune system. Immunol Cell Biol 2009; 87:113-9.
6. Pradeu T, Carosella ED. On the definition of a criterion of immunogenicity. Proc Natl Acad Sci USA 2006; 103:17858-61.
7. Kyte J, Doolittle RF. A simple method for displaying the hydropathic character of a protein. J Mol Biol 1982; 157:105-32.
8. Manavalan P, Ponnuswamy PK. Hydrophobic character of amino acid residues in globular proteins. Nature 1978; 275:673-4.
9. Sweet RM, Eisenberg D. Correlation of sequence hydrophobicities measures similarity in three-dimensional protein structure. J Mol Biol 1983; 171:479-88.
10. Parker JMR, Guo D, Hodges RS. New hydrophilicity scale derived from high-performance liquid chromatography retention data: correlation of predicted surface residues with antigenicity and X-ray derived accessible sites. Biochemistry 1986; 25:5425-32.
11. Thornton JM, Edwards MS, Tayler WR, Barlow DJ. Location of 'continuous' antigenic determinants in the protruding regions of proteins. EMBO J 1986; 5:409-13.
12. Karplus PA, Schulz GE. Prediction of chain flexibility in proteins: a tool for the selection of peptide antigens. Naturwissenschaften 1985; 72:212-3.
13. Garnier J, Robson B. The GOR method for predicting secondary structures in proteins. In: Fasman GD, editor. Prediction of Protein Structure and the Principles of Protein Conformation. Vol. 11. Plenum Press 1989; 417-65.
14. Lewis PN, Momany FA, Scheraga HA. Folding of polypeptide chains in proteins: a proposed mechanism for folding. Proc Natl Acad Sci USA 1971; 68:2293-7.
15. Blythe MJ, Flower DR. Benchmarking B cell epitope prediction: underperformance of existing methods. Protein Sci 2005; 14:246-8.
16. Gowthaman U, Agrewala JN. In silico tools for predicting peptides binding to HLA-class II molecules: more confusion than conclusion. J Proteome Res 2008; 7:154-63.
17. Lucchese G, Stufano A, Trost B, Kusalik A, Kanduc D. Peptidology: short amino acid modules in cell biology and immunology. Amino Acids 2007; 33:703-7.
18. El-Manzalawy Y, Dobbs D, Honavar V. Predicting flexible length linear B-cell epitopes. Comput Syst Bioinformatics Conf 2008; 7:121-32.
19. Sollner J, Grohmann R, Rapberger R, Perco P, Lukas A, Mayer B. Analysis and prediction of protective continuous B-cell epitopes on pathogen proteins. Immunome Res 2008; 4:1.
20. Willers J, Lucchese A, Kanduc D, Ferrone S. Molecular mimicry of phage displayed peptides mimicking GD3 ganglioside. Peptides 1999; 20:1021-6.
21. Natale C, Giannini T, Lucchese A, Kanduc D. Computer-assisted analysis of molecular mimicry between human papillomavirus 16 E7 oncoprotein and human protein sequences. Immunol Cell Biol 2000; 78:580-5.
22. Kanduc D, Fanizzi FP, Lucchese G, Stevanovic S, Sinha AA, Mittelman A. NMR probing of in silico identification of anti-HPV16 E7 mAb linear peptide epitope. Peptides 2004; 25:243-50.
23. Mittelman A, Tiwari R, Lucchese G, Willers J, Dummer R, Kanduc D. Identification of monoclonal anti-HMW-MAA antibody linear peptide epitope by proteomic database mining. J Invest Dermat 2004; 123:670-5.
24. Dummer R, Mittelman A, Fanizzi FP, Lucchese G, Willers J, Kanduc D. Nonself discrimination as a driving concept in the identification of an immunodominant HMW-MAA epitopic peptide sequence by autoantibodies from melanoma cancer patients. Int J Cancer 2004; 111:720-6.
25. Willers J, Lucchese A, Mittelman A, Dummer R, Kanduc D. Definition of anti-tyrosinase MAb T311 linear determinant by proteome-based similarity analysis. Exp Dermatol 2005; 14:543-50.
26. Angelini G, Bonamonte D, Lucchese A, Favia G, Serpico R, Mittelman A, et al. Preliminary data on Pemphigus vulgaris treatment by a proteomics-defined peptide: a case report. J Transl Med 2006; 4:43.
27. Kanduc D, Tessitore L, Lucchese G, Kusalik A, Farber E, Marincola FM. Sequence uniqueness and sequence variability as modulating factors of human anti- HCV humoral immune response. Cancer Immunol Immunother 2008; 57:1215-23.
28. Kanduc D. Correlating low-similarity peptide sequences and allergenic epitopes. Curr Pharm Des 2008; 14:289-95.
29. Kanduc D. "Self-Nonself" peptides in the vaccine design. Curr Pharm Des 2009; 15:3283-9.
30. Kanduc D, Serpico R, Lucchese A, Shoenfeld Y. Correlating low-similarity peptide sequences and HIV B-cell epitopes. Autoimmun Rev 2008; 7:291-6.
31. Stufano A, Kanduc D. Proteome-based epitopic peptide scanning along PSA. Exp Mol Pathol 2009; 86:36-40.
32. Gavalas NG, Gottumukkala RV, Gawkrodger DJ, Watson PF, Weetman AP, Kemp H. Mapping of melanin-concentrating hormone receptor 1 B cell epitopes predicts two major binding sites for vitiligo patient autoantibodies. Exp Dermatol 2009; 18:454-63.
33. Dai J, Cao Z, Kang Y, Fan K, Ji G, Yang H, et al. A functional motif QLYxxYP is essential for osteopontin induced T lymphocyte activation and migration. Biochem Biophys Res Commun 2009; 380:715-20.
34. Kessel C, Kreuz W, Klich K, Becker-Peters K, Vorpahl F, Dietrich U, et al. Multimerization of peptide mimotopes for blocking of Factor VIII neutralizing antibodies. ChemMedChem 2009; 4:1364-70.
35. By Y, Durand-Gorde JM, Condo J, Lejeune PJ, Mallet B, Carayon P, et al. Production of an agonist-like monoclonal antibody to the human A2A receptor of adenosine for clinical use. Mol Immunol 2009; 46:400-5.
36. Reynolds J, Abbott DS, Karegli J, Evans DJ, Pusey CD. Mucosal tolerance induced by an immunodominant peptide from rat {alpha}3(IV)NC1 in established experimental autoimmune glomerulonephritis. Am J Pathol 2009; 174:2202-10.
37. Gardberg AS, Dice L, Pridgen K, Ko J, Patterson P, Ou S, et al. The x-ray structures of amyloid beta-related peptides complexed to antibodies. Biochemistry 2009; 48:5210-7.
38. Houimel M, Mazzucchelli L. Identification of biologically active peptides that inhibit binding of human CXCL8 to its receptors from a random phage-epitope library. J Leukoc Biol 2009; 85:728-38.
39. Mihaylova N, Voynova E, Tchorbanov A, Dolashka- Angelova P, Bayry J, Devreese B, et al. Simultaneous engagement of FcgammaIIb and CD22 inhibitory receptors silences targeted B cells and suppresses autoimmune disease activity. Mol Immunol 2009; 47:123-30.
40. Shin KH, Jeong KY, Hong CS, Yong TS. IgE binding reactivity of peptide fragments of Bla g 4, a major German cockroach allergen. Korean J Parasitol 2009; 47:31-6.
41. Zakzuk J, Jiménez S, Cheong N, Puerta L, Lee BW, Chua KY, et al. Immunological characterization of a Blo t 12 isoallergen: identification of immunoglobulin E epitopes. Clin Exp Allergy 2009; 39:608-16.
42. Benferhat R, Krust B, Rey-Cuillé MA, Hovanessian AG. The caveolin-1 binding domain of HIV-1 glycoprotein gp41 (CBD1) contains several overlapping neutralizing epitopes. Vaccine 2009; 27:3620-30.
43. Fiebig U, Schmolke M, Eschricht M, Kurth R, Denner J. Mode of interaction between the HIV-1-neutralizing monoclonal antibody 2F5 and its epitope. AIDS 2009; 23:887-95.
44. Pejchal R, Gach JS, Brunel FM, Cardoso RM, Stanfield RL, Dawson PE, et al. A conformational switch in HIV gp41 revealed by the structures of overlapping epitopes recognized by neutralizing antibodies. J Virol 2009; 83:8451-62.
45. Zhou YJ, Yu H, Tian ZJ, Liu JX, An TQ, Peng JM, et al. Monoclonal antibodies and conserved antigenic epitopes in the C terminus of GP5 protein of the North American type porcine reproductive and respiratory syndrome virus. Vet Microbiol 2009; 138:1-10.
46. Houimel M, Dellagi K. Peptide mimotopes of rabies virus glycoprotein with immunogenic activity. Vaccine 2009; 27:4648-55.
47. Wang B, Hua RH, Tian ZJ, Chen NS, Zhao FR, Liu TQ, et al. Identification of a virus-specific and conserved B-cell epitope on NS1 protein of Japanese encephalitis virus. Virus Res 2009; 141:90-5.
48. Wang SF, Chen KH, Thitithanyanont A, Yao L, Lee YM, Chan YJ, et al. Generating and characterizing monoclonal and polyclonal antibodies against avian H5N1 hemagglutinin protein. Biochem Biophys Res Commun 2009; 382:691-6.
49. Khurana S, Suguitan AL Jr, Rivera Y, Simmons CP, Lanzavecchia A, Sallusto F, et al. Antigenic fingerprinting of H5N1 avian influenza using convalescent sera and monoclonal antibodies reveals potential vaccine and diagnostic targets. PLoS Med 2009; 6:1000049.
50. Prabhu N, Prabakaran M, Ho HT, Velumani S, Qiang J, Goutama M, et al. Monoclonal antibodies against the fusion peptide of hemagglutinin protect mice from lethal influenza A virus H5N1 infection. J Virol 2009; 83:2553-62.
51. Li Y, Han WY, Li ZJ, Lei LC. Klebsiella pneumoniae MrkD adhesin-mediated immunity to respiratory infection and mapping the antigenic epitope by phage display library. Microb Pathog 2009; 46:144-9.
52. Beernink PT, LoPasso C, Angiolillo A, Felici F, Granoff D. A region of the N-terminal domain of meningococcal factor H-binding protein that elicits bactericidal antibody across antigenic variant groups. Mol Immunol 2009; 46:1647-53.
53. Koshland DJ Jr. Recognizing self from nonself. Science 1990; 248:4961.